Metabolic effects of treatment with atypical antipsychotics

Journal of Clinical Psychiatry

Volumn 65, Issue 11, 2004, Pages 1447-1455

  Kane, John M ^a   Barrett, Eugene J ^b   Casey, Daniel E ^c   Correll, Christoph U ^a   Gelenberg, Alan J ^d   Klein, Samuel ^e   Newcomer, John W ^e  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; BODY MASS; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; CHILD; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DRUG EFFECT; DRUG LABELING; FOOD AND DRUG ADMINISTRATION; HEALTH SURVEY; HUMAN; HYPERLIPIDEMIA; MEDICAL EDUCATION; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRACTICE GUIDELINE; PREVALENCE; PSYCHOSIS; SCHIZOPHRENIA; STANDARD; UNITED STATES;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BODY MASS INDEX; BODY WEIGHT; CHILD; CONSENSUS DEVELOPMENT CONFERENCES; DIABETES MELLITUS, TYPE 2; DRUG LABELING; EDUCATION, MEDICAL, CONTINUING; HEALTH SURVEYS; HUMANS; HYPERLIPIDEMIAS; OBESITY; PRACTICE GUIDELINES; PREVALENCE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 15944406427     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n1102     Document Type: Note

References (0)